Italian GP Alto Partners has acquired an 80% stake in Italy-based Officina Farmaceutica Italiana (OFI), a family-owned contract manufacturer of dermo-cosmetic and nutritional products, and medical devices.
The GP acquired the stake in the business via its Alto Capital IV fund, which closed on €210m in April this year. The vehicle targets companies generating revenues in the €20-80m bracket.
The partnership will have the objective of fostering product development and help the company expand via acquisitions of smaller companies in the sector. Alberto Donati, the son of OFI's founder, will remain the chairman of the company.
Founded by Attilio Donati in 1946, OFI produces dermo-cosmetic and dietary products, and medical devices, on behalf of third parties and for its own brands.
Based in Bergamo, OFI generates a €18m turnover. According to the Italian online newschannel Be Beez, the group has an EBITDA margin of 16%.
Officina Farmaceutica Italiana – Alberto Donati (chairman).
Vehicle was registered in Luxembourg in September 2018 and held a first close earlier in the year
Fund will follow the same strategy as its predecessor, Accel London V, which raised €500m
GP sells Dutch petrochemical business BRB to Malaysia-based peer Petronas Chemicals Group
GP acquires a 37.5% stake in the low-calorie drinks brand and typically writes cheques of up to £10m